GlassScriptPhysician profile
Karen L Collins
NPI 1114940236
$1,695.13
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $232 · 2021: $529 · 2022: $435 · 2023: $315 · 2024: $31.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $389.89 | 2019-2024 | Lo Loestrin Fe, Orilissa |
| Exeltis, USA INC. | $180.32 | 2020-2022 | |
| Pfizer INC. | $162.51 | 2020-2023 | |
| Amgen INC. | $91.37 | 2019-2023 | Prolia, Evenity |
| Agile Therapeutics, INC. | $89.10 | 2021-2022 | |
| Aspira Women'S Health INC | $87.35 | 2022 | |
| Therapeuticsmd, INC. | $74.15 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $68.15 | 2022-2023 | |
| Hologic Sales and Service, LLC | $58.85 | 2023 | Coolseal Generator, Aptima, Thinprep 2000 Processor |
| Organon LLC | $56.10 | 2021-2022 | |
| Daiichi Sankyo INC. | $50.68 | 2019 | |
| Merck Sharp & Dohme LLC | $40.59 | 2019-2021 | |
| Abbott Laboratories | $38.80 | 2021 | |
| Ibsa Pharma INC. | $33.18 | 2022-2023 | Tirosint, Licart |
| Evofem Biosciences, INC. | $29.77 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $25.32 | 2023 | Myfembree |
| Myovant Sciences INC. | $24.95 | 2022 | |
| Allergan, INC. | $24.61 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.46 | 2020 | |
| Avion Pharmaceuticals | $23.62 | 2023 | Balcoltra |
| Shield Therapeutics INC | $22.04 | 2022 | |
| Amneal Pharmaceuticals LLC | $20.14 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $19.28 | 2021 | |
| Lupin INC. | $17.67 | 2020 | |
| Coopersurgical, INC. | $16.00 | 2021 | |
| Ascend Therapeutics US, LLC | $13.23 | 2021 | |
| Dysis Medical, INC. | $13.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.